Shares of Moderna Inc. MRNA, +2.23% advanced 2.23% to $129.28 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP, -0.28% falling 0.28% to 12,795.55 and Dow Jones Industrial Average DJIA, -0.48% falling 0.56% to 32,632.64. The stock’s rise snapped a five-day losing streak. Moderna Inc. closed $368.21 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV, -1.54% fell 1.54% to $147.15, Amgen Inc. AMGN, -1.39% fell 1.39% to $231.10, and AstraZeneca PLC ADR AZN, +2.11% rose 2.11% to $57.69. Trading volume (6.6 M) remained 1.8 million below its 50-day average volume of 8.4 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
from WordPress https://ift.tt/UvbBy0D
via IFTTT